CN108651988A - Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof - Google Patents
Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN108651988A CN108651988A CN201810444527.1A CN201810444527A CN108651988A CN 108651988 A CN108651988 A CN 108651988A CN 201810444527 A CN201810444527 A CN 201810444527A CN 108651988 A CN108651988 A CN 108651988A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- nephrosis
- fat
- clinical nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000502 dialysis Methods 0.000 title claims abstract description 59
- 206010029164 Nephrotic syndrome Diseases 0.000 title claims abstract description 51
- 208000009928 nephrosis Diseases 0.000 title claims abstract description 51
- 231100001027 nephrosis Toxicity 0.000 title claims abstract description 51
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 50
- 230000035764 nutrition Effects 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000009472 formulation Methods 0.000 title claims description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 35
- 229940088594 vitamin Drugs 0.000 claims abstract description 31
- 229930003231 vitamin Natural products 0.000 claims abstract description 31
- 235000013343 vitamin Nutrition 0.000 claims abstract description 31
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 25
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- 230000035622 drinking Effects 0.000 claims abstract description 22
- 235000008216 herbs Nutrition 0.000 claims abstract description 22
- 230000010354 integration Effects 0.000 claims abstract description 22
- 235000013305 food Nutrition 0.000 claims abstract description 19
- 235000005911 diet Nutrition 0.000 claims abstract description 17
- 239000004615 ingredient Substances 0.000 claims abstract description 17
- 230000037213 diet Effects 0.000 claims abstract description 15
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 239000011573 trace mineral Substances 0.000 claims abstract description 12
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims description 108
- 235000019197 fats Nutrition 0.000 claims description 28
- 235000018102 proteins Nutrition 0.000 claims description 24
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 23
- 235000010469 Glycine max Nutrition 0.000 claims description 22
- 210000003734 kidney Anatomy 0.000 claims description 21
- 241000196324 Embryophyta Species 0.000 claims description 20
- 244000068988 Glycine max Species 0.000 claims description 20
- 235000013399 edible fruits Nutrition 0.000 claims description 18
- 244000268590 Euryale ferox Species 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 235000015097 nutrients Nutrition 0.000 claims description 15
- 235000006487 Euryale ferox Nutrition 0.000 claims description 14
- 244000197580 Poria cocos Species 0.000 claims description 14
- 235000008599 Poria cocos Nutrition 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 14
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 13
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 13
- 244000241838 Lycium barbarum Species 0.000 claims description 13
- 235000014633 carbohydrates Nutrition 0.000 claims description 13
- 239000000839 emulsion Substances 0.000 claims description 13
- 235000013312 flour Nutrition 0.000 claims description 13
- 241000208671 Campanulaceae Species 0.000 claims description 12
- 108010010803 Gelatin Proteins 0.000 claims description 12
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 12
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 12
- 235000019688 fish Nutrition 0.000 claims description 12
- 239000008273 gelatin Substances 0.000 claims description 12
- 229920000159 gelatin Polymers 0.000 claims description 12
- 235000019322 gelatine Nutrition 0.000 claims description 12
- 235000011852 gelatine desserts Nutrition 0.000 claims description 12
- 235000012054 meals Nutrition 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 241000251468 Actinopterygii Species 0.000 claims description 11
- 241000287826 Gallus Species 0.000 claims description 11
- 229920002774 Maltodextrin Polymers 0.000 claims description 11
- 239000005913 Maltodextrin Substances 0.000 claims description 11
- 240000007651 Rubus glaucus Species 0.000 claims description 11
- 229940035034 maltodextrin Drugs 0.000 claims description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 10
- 235000010489 acacia gum Nutrition 0.000 claims description 10
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 10
- 235000019198 oils Nutrition 0.000 claims description 10
- 239000011669 selenium Substances 0.000 claims description 10
- 229910052711 selenium Inorganic materials 0.000 claims description 10
- 108010038807 Oligopeptides Proteins 0.000 claims description 9
- 102000015636 Oligopeptides Human genes 0.000 claims description 9
- 235000004347 Perilla Nutrition 0.000 claims description 9
- 244000124853 Perilla frutescens Species 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000003240 coconut oil Substances 0.000 claims description 9
- 235000019864 coconut oil Nutrition 0.000 claims description 9
- 239000004006 olive oil Substances 0.000 claims description 9
- 235000008390 olive oil Nutrition 0.000 claims description 9
- 239000003549 soybean oil Substances 0.000 claims description 9
- 235000012424 soybean oil Nutrition 0.000 claims description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 9
- 241000206575 Chondrus crispus Species 0.000 claims description 8
- 108010073771 Soybean Proteins Proteins 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 235000019710 soybean protein Nutrition 0.000 claims description 8
- 235000008939 whole milk Nutrition 0.000 claims description 8
- 229920002261 Corn starch Polymers 0.000 claims description 7
- 241000287828 Gallus gallus Species 0.000 claims description 7
- 239000005862 Whey Substances 0.000 claims description 7
- 102000007544 Whey Proteins Human genes 0.000 claims description 7
- 108010046377 Whey Proteins Proteins 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 7
- 210000003022 colostrum Anatomy 0.000 claims description 7
- 235000021277 colostrum Nutrition 0.000 claims description 7
- 239000008120 corn starch Substances 0.000 claims description 7
- 229940099112 cornstarch Drugs 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 229960003080 taurine Drugs 0.000 claims description 7
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 6
- 241000972773 Aulopiformes Species 0.000 claims description 6
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 6
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 6
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 6
- 241000233866 Fungi Species 0.000 claims description 6
- 240000004922 Vigna radiata Species 0.000 claims description 6
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 6
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 235000010419 agar Nutrition 0.000 claims description 6
- 239000011162 core material Substances 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- 235000013373 food additive Nutrition 0.000 claims description 6
- 239000002778 food additive Substances 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 235000019515 salmon Nutrition 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 5
- 229920002752 Konjac Polymers 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 239000000605 aspartame Substances 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 5
- 229960003438 aspartame Drugs 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 235000003132 food thickener Nutrition 0.000 claims description 5
- 239000003205 fragrance Substances 0.000 claims description 5
- 239000004519 grease Substances 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 229920002907 Guar gum Polymers 0.000 claims description 4
- 108090000942 Lactalbumin Proteins 0.000 claims description 4
- 102000004407 Lactalbumin Human genes 0.000 claims description 4
- 240000003183 Manihot esculenta Species 0.000 claims description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 4
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- -1 is uniformly mixed Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 235000013594 poultry meat Nutrition 0.000 claims description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 3
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 3
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 3
- 241000238557 Decapoda Species 0.000 claims description 3
- 229920002581 Glucomannan Polymers 0.000 claims description 3
- 108090001030 Lipoproteins Proteins 0.000 claims description 3
- 102000004895 Lipoproteins Human genes 0.000 claims description 3
- 229920000161 Locust bean gum Polymers 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 229940046240 glucomannan Drugs 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000000252 konjac Substances 0.000 claims description 3
- 235000010485 konjac Nutrition 0.000 claims description 3
- 235000010420 locust bean gum Nutrition 0.000 claims description 3
- 239000000711 locust bean gum Substances 0.000 claims description 3
- 229940100688 oral solution Drugs 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 2
- 235000000832 Ayote Nutrition 0.000 claims description 2
- 241000167854 Bourreria succulenta Species 0.000 claims description 2
- 241001107116 Castanospermum australe Species 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- 235000007354 Coix lacryma jobi Nutrition 0.000 claims description 2
- 244000077995 Coix lacryma jobi Species 0.000 claims description 2
- 240000004244 Cucurbita moschata Species 0.000 claims description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 2
- 241000371652 Curvularia clavata Species 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 240000001008 Dimocarpus longan Species 0.000 claims description 2
- 240000005717 Dioscorea alata Species 0.000 claims description 2
- 235000000235 Euphoria longan Nutrition 0.000 claims description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 2
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 2
- 241000408747 Lepomis gibbosus Species 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 235000009811 Momordica charantia Nutrition 0.000 claims description 2
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 2
- 240000001740 Momordica dioica Species 0.000 claims description 2
- 235000018365 Momordica dioica Nutrition 0.000 claims description 2
- 240000002853 Nelumbo nucifera Species 0.000 claims description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 241000287420 Pyrus x nivalis Species 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- 244000062793 Sorghum vulgare Species 0.000 claims description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 2
- 244000300264 Spinacia oleracea Species 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 2
- 240000001417 Vigna umbellata Species 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000015278 beef Nutrition 0.000 claims description 2
- 235000021279 black bean Nutrition 0.000 claims description 2
- 235000019693 cherries Nutrition 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 235000019713 millet Nutrition 0.000 claims description 2
- 235000015136 pumpkin Nutrition 0.000 claims description 2
- 235000020236 pumpkin seed Nutrition 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims 3
- 241000512259 Ascophyllum nodosum Species 0.000 claims 1
- 244000088415 Raphanus sativus Species 0.000 claims 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims 1
- 125000005457 triglyceride group Chemical group 0.000 claims 1
- 235000019871 vegetable fat Nutrition 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 abstract description 12
- 230000004054 inflammatory process Effects 0.000 abstract description 12
- 230000006870 function Effects 0.000 abstract description 10
- 239000001301 oxygen Substances 0.000 abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 abstract description 6
- 230000008439 repair process Effects 0.000 abstract description 5
- 230000006641 stabilisation Effects 0.000 abstract description 5
- 238000011105 stabilization Methods 0.000 abstract description 5
- 230000003915 cell function Effects 0.000 abstract description 4
- 238000002649 immunization Methods 0.000 abstract description 4
- 230000003053 immunization Effects 0.000 abstract description 4
- 210000004927 skin cell Anatomy 0.000 abstract description 4
- 208000002720 Malnutrition Diseases 0.000 description 16
- 230000001071 malnutrition Effects 0.000 description 16
- 235000000824 malnutrition Nutrition 0.000 description 16
- 208000015380 nutritional deficiency disease Diseases 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- 238000001631 haemodialysis Methods 0.000 description 12
- 208000033626 Renal failure acute Diseases 0.000 description 11
- 201000011040 acute kidney failure Diseases 0.000 description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 208000020832 chronic kidney disease Diseases 0.000 description 9
- 229940091258 selenium supplement Drugs 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 8
- 230000003907 kidney function Effects 0.000 description 8
- 208000009304 Acute Kidney Injury Diseases 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 208000012998 acute renal failure Diseases 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 229920001503 Glucan Polymers 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 208000001647 Renal Insufficiency Diseases 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 235000013734 beta-carotene Nutrition 0.000 description 5
- 239000011648 beta-carotene Substances 0.000 description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 5
- 229960002747 betacarotene Drugs 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 201000006370 kidney failure Diseases 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 229940091250 magnesium supplement Drugs 0.000 description 5
- 229940055726 pantothenic acid Drugs 0.000 description 5
- 235000019161 pantothenic acid Nutrition 0.000 description 5
- 239000011713 pantothenic acid Substances 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 235000014786 phosphorus Nutrition 0.000 description 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 239000011715 vitamin B12 Substances 0.000 description 5
- 239000011726 vitamin B6 Substances 0.000 description 5
- 239000011647 vitamin D3 Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 244000017020 Ipomoea batatas Species 0.000 description 4
- 235000002678 Ipomoea batatas Nutrition 0.000 description 4
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 4
- 229930003270 Vitamin B Natural products 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 229910052748 manganese Inorganic materials 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920001592 potato starch Polymers 0.000 description 4
- 238000004393 prognosis Methods 0.000 description 4
- 201000003068 rheumatic fever Diseases 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 239000002023 wood Substances 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 101710089165 Protein white Proteins 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000008327 renal blood flow Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 2
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 2
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- 206010027417 Metabolic acidosis Diseases 0.000 description 2
- 206010058116 Nephrogenic anaemia Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 229960002478 aldosterone Drugs 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000011017 operating method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- 208000013725 Chronic Kidney Disease-Mineral and Bone disease Diseases 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010060766 Heteroplasia Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020466 Hunger Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000003979 Mineralocorticoid Receptors Human genes 0.000 description 1
- 108090000375 Mineralocorticoid Receptors Proteins 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 240000002547 Rosa roxburghii Species 0.000 description 1
- 235000000640 Rosa roxburghii Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108700028909 Serum Amyloid A Proteins 0.000 description 1
- 102000054727 Serum Amyloid A Human genes 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007485 conventional hemodialysis Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 201000005991 hyperphosphatemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 231100001028 renal lesion Toxicity 0.000 description 1
- 201000006409 renal osteodystrophy Diseases 0.000 description 1
- 230000001084 renoprotective effect Effects 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 239000002441 uremic toxin Substances 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a kind of nephrosis dialysis tailored version clinical nutrition formula, including following component and its parts by weight:15 25 parts of protein, 8 12 parts of fat, 50 54 parts of carbohydrate, 35 parts of dietary fibers, 0.3 0.6 parts of macroelements, 0.01 0.05 parts of trace elements, 0.005 0.02 parts of liposoluble vitamins, 0.01 0.2 parts of water soluble vitamins, 0.05 1 parts of diet essence, 0.05 2 parts of integration of drinking and medicinal herbs ingredients, 0.1 3 parts of natural plants compounds and 0.005 2 parts of new resource foods;The present invention also provides the preparation methods of above-mentioned clinical nutrition formula.The present invention can provide balanced nutriment for nephrosis dialysis patient, can keep the stabilization of patient body quality, booster immunization responsibility, repair function, the state that reduces inflammation, improve oxygen radical removing ability and inner skin cell function.
Description
Technical field
The present invention relates to nutrient formulation field more particularly to a kind of nephrosis dialysis tailored version clinical nutrition formula and its preparations
Method.
Background technology
Kidney is the vitals for having in human body excretion, metabolism and endocrine function, it can be each histoorgan of human body
Generated various metabolites, the especially metabolic waste of protein, are excreted by urine in metabolic process, with dimension
Hold the balance of human body water, electrolyte and soda acid.Therefore, kidney is to having very important effect body metabolism.
Kidney failure refers to the pathological state that renal function is partly or entirely lost, and kidney failure can be divided into acute renal failure and slow
Property kidney failure, the disease progression of acute renal failure is quick, typically because of renal blood flow insufficient (such as wound or burn), kidney
Function is impaired caused by certain factor is blocked or is injured by poisonous substance, and the generation of acute renal failure is caused;Chronic renal failure
Main cause is long-term renal lesions, and with the progress of time and disease, the function of kidney is gradually reduced, and causes kidney failure
Occur.
The state of an illness of acute renal failure is critical, and the death rate is high, and curative effect is slower if imposing liquid expectant treatment merely, with
The progress at full speed of modern medicine, haemodialysis are a kind of partial alternative renal functions, race against time for kidney reparation and regeneration
Important measures just like have become the basic hand of most of acute nephropathy patient treatments with the popularization and promotion of dialysis
Section;Hemodialysis is carried out as early as possible for the patient of acute renal failure, can prevent and reduce patient's multiple organ failure
And the generation of other severe complications.The advantages of haemodialysis, mainly has:The patient overweight to volume load can remove it in vivo
Excessive moisture;Remove the toxin such as creatinine, urea nitrogen;Patient's potassemia and metabolic acidosis are corrected to stablize patient's body
Interior environment;Contribute to the intake of liquid, heat, protein and other nutriments;It can also will be infectious caused by protopathy
Inflammatory mediator, such as:Interleukins, tumor necrosis factor give in vitro;Be conducive to the reparation and regeneration of injury of kidney cell.So
And due to various reasons, in dialysis patient, 23%~76% has malnutrition, wherein 6%~8% patient has serious nutrition
It is bad.One of an important factor for malnutrition is these patients ' life qualities of influence and prognosis at a specified future date.Malnutrition can make dialysis
The immune function of patient reduces, aggravation of anemia and is easy to infect, and influences the organ dysfunctions such as the heart, lung, brain, makes patients ' life quality
It reduces, case fatality rate increases.
As China gradually steps into aging society, the health problem of mid-aged population is increasingly becoming society and clinical concern
Focus, susceptible disease disease of the chronic renal failure as the middle-aged and the old seriously affected the health and quality of life of patient, when
Preceding majority person in middle and old age's patients with chronic renal failure is sustained life using the mode of haemodialysis.Haemodialysis is clinically to be used to treat
A kind of conventional therapy of chronic renal failure can replace renal function, by blood drainage to haemodialysis control unit, carry out blood
With the mass exchange of dialyzate, to achieve the effect that remove patient's body excess moisture metabolite, maintain Water-Electrolyte and
Acid-base balance.However, according to incompletely statistics, there is malnutritive symptom, wherein severe malnutrition person very in about 5 one-tenth dialysis patients
To accounting for 20%~30%, the health of patient is seriously threatened, influences its quality of life.Therefore, how before ensuring curative effect
It puts to improve and also becomes the hot issue that each scholar probes into using person in middle and old age's patients with chronic renal failure nutritional status of haemodialysis.
With going deep into for correlative study, some scholars point out that maintenance hemodialysis (MHD) can effectively make up conventional hemodialysis drawback,
To promoting patient's prognosis promotion and Prognosis that there is actively impact.
Correlative study shows malnutritive one of the common complication as haemodialysis, seriously affects minimal invasive treatment's matter
Amount, some scholars are discussed with regard to its risk factor, it is found that the age is the increased risk for threatening patient malnutritive symptom occur
One of factor prompts clinic that person in middle and old age's Chronic Renal Failure Patients should be classified as to emphasis monitoring and early intervention object, carries out related drink
Food and nutritional intervention work reduce its malnutritive occurrence risk, General Promotion patient's prognostic level with this.
Therefore, periodically to dialysis patient, especially person in middle and old age's Chronic Renal Failure Patients, carry out Nutrition Evaluation be follow-up of patients and
The leading indicator of monitoring.It is worth noting that physical presence two kinds of malnutrition in dialysis patient:I type nutrition is not
Good, also referred to as simple malnutritive, i.e., its malnutrition is mainly because protein and Energy intaking deficiency cause, while dialysing not
Fully, metabolic acidosis causes body catabolism to enhance, and malnutrition can be further aggravated, and this type of malnutrition serum is white
Protein level is normal or reduces, and is often improved by reinforcing dialysis and extra-nutrition;II type malnutrition mainly has with inflammation
It closes, passes through inflammatory mediator and cell factor C reactive protein, amyloid A, interleukin 1, interleukin-6, tumour
The release of necrosin a etc. causes malnutrition, although malnutrition can still occur for this type of fully dialysis.Wherein, C- reacts egg
It is used as a kind of acute phase reactive protein in vain, is the reliable reflection of internal level of inflammation, by widely as the mark of inflammatory reaction.
The incidence of the annual end-stage renal disease in China is more than 10/,100,000 populations, and is increased with annual 18% growth rate
It is long.Although the technology of dialysis is constantly progressive, the time-to-live of dialysis patient is also constantly extending, and still has 20% renal failure every year
Patient is exhausted to die of illness.Since one of the main reason for influencing the high case fatality rate of dialysis patient and complication rate is exactly generally existing
Malnutrition, but the enteral nutrition preparation for being directed to dialysis patient currently on the market is seldom, therefore solve dialysis patient nutrition not
Good specific full nutrition enteral nutrition preparation is extremely urgent.
Acute renal failure (Acute Renal Failure, ARF) is a kind of clinical syndrome with high mortality,
Prognosis and the general immunity and metabolism status of ARF patient are closely related, and ARF usually causes oxidative stress and inflammatory conditions, nutrition
It is bad to aggravate these reactions;In addition, the malnutrition of already present pure is (mainly because of protein before some morbidities
Cause with Energy intaking deficiency) or the malnutrition (mainly and inflammation-related) of Nosocomial be regarded as leading to acute kidney
An important factor for failure patients' death rate persistently increases.Therefore, ARF patient takes corresponding enteral nutrition system while dialysis
Agent can keep the stabilization of body quality, booster immunization responsibility, repair function, the state that reduces inflammation, improve oxygen radical
Scavenging activity and inner skin cell function help to reduce nephrosis dialysis patient case fatality rate and complication rate, reduce patient
Underfed occurrence risk promotes the prognostic level of patient.
A kind of enteral nutrition preparation and preparation method thereof for dialysis patient disclosed in Chinese patent CN105519961A,
Its formula is only added to protein, fat and carbohydrate, although the nutrition and metabolism demand of dialysis patient can be supplemented,
But its be directed to the suitable dietary fiber of dialysis patient addition, diet essence, integration of drinking and medicinal herbs ingredient, natural plants compound with
And the special dietaries substance such as new resource food, it cannot preferably help nephrosis dialysis patient to improve body quality, it is extensive to accelerate the state of an illness
It is multiple.
Therefore, the nutrition and metabolism demand of nephrosis dialysis patient can either be met by developing, and can improve patient body matter
Amount accelerates the product that the state of an illness is restored, and has important value and wide market.
Invention content
The purpose of the present invention is to overcome the defects in the prior art, provides a kind of nephrosis dialysis tailored version clinical nutrition and matches
Side and preparation method thereof, according to nephrotic, the simple malnutritive or hospital of generally existing obtains during haemodialysis
The underfed feature of property is obtained, balanced nutriment is provided, stabilization, the booster immunization response of patient body quality can be kept
Ability, repair function, improve oxygen radical removing ability and inner skin cell function at the state that reduces inflammation, and help to reduce kidney
Sick dialysis patient case fatality rate and complication rate reduce the underfed occurrence risk of patient, promote the prognostic level of patient.
To achieve the above object, the present invention adopts the following technical scheme that:
The first purpose of the invention is to provide a kind of nephrosis dialyse tailored version clinical nutrition formula, including following component and
Its parts by weight:15-25 parts of protein, 8-12 parts of fat, 50-54 parts of carbohydrate, 3-5 parts of dietary fibers, 0.3-0.6 parts
Macroelement, 0.01-0.05 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.01-0.2 parts of water soluble vitamins,
The new money of 0.05-1 parts of diet essence, 0.05-2 parts of integration of drinking and medicinal herbs ingredients, 0.1-3 parts of natural plants compounds and 0.005-2 parts
Source food;
Wherein, in the nutrient formulation, protein:Fat:The productivity ratio of carbohydrate is 15~20:20~25:50
~60.
Wherein, the integration of drinking and medicinal herbs ingredient include Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, campanulaceae, Gorgon fruit, Chinese yam,
At least one of hawthorn, Gallus domesticlus brisson, donkey-hide gelatin.
In order to advanced optimize above-mentioned technical proposal, the technical measures that the present invention is taken further include:
Further, protein:Fat:The productivity ratio of carbohydrate is 18.6:24.1:57.3.
Further, the protein includes that lactalbumin, soybean protein isolate, whole milk powder, dried whole-egg, marine fish are low
At least one of poly- peptide, colostrum, taurine;Further, the protein be lactalbumin, soybean protein isolate,
Whole milk powder, dried whole-egg, ocean fish oligopeptide, colostrum, taurine.
Further, the parts by weight of the fat are 9~11 parts;Further, the parts by weight of the fat are
10.7 parts.
Further, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structures
At least one of fat, DHA, EPA, ARA, phosphatide.
Further, the fat includes ω -6 unsaturated fatty acids and omega-3 unsaturated fatty acid, wherein ω -6 insatiable hungers
It is 4 with the ratio of aliphatic acid and omega-3 unsaturated fatty acid:1.
Further, the fat includes medium chain triglyceride, olive oil, soybean oil, coconut oil, perilla herb oil.
Further, the carbohydrate includes fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch
In at least two.
Further, the dietary fiber includes inulin, konjaku flour, galactooligosaccharide, oligofructose, oligomeric different malt
At least one of sugar, soybean polyoses, cyclodextrin, resistant dextrin, soybean fiber;Further, the dietary fiber includes
At least one of galactooligosaccharide and oligoisomaltose.
Further, the dietary fiber selects water-soluble dietary fiber.
Further, the macroelement includes calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, calcium carbonate, gluconic acid
At least one of potassium, potassium chloride, sodium chloride, sodium citrate, magnesium gluconate, magnesium carbonate.
Further, trace element includes ferrous gluconate, potassium iodide, zinc gluconate, sodium selenite, gluconic acid
At least one of copper, copper sulphate, chromium sulfate, chromium chloride, manganese sulfate, manganese gluconate and sodium molybdate.
Further, the parts by weight of selenium are 0.00001~0.0001 part in the trace element;Further, institute
The parts by weight for stating selenium in trace element are 0.00006 part.
Further, the liposoluble vitamin includes vitamin A, beta carotene, vitamin D3, vitamin E, dimension life
Plain K1At least one of.
Further, the water soluble vitamin includes vitamin B1, vitamin B2, vitamin B6, vitamin B12, dimension life
At least one of plain C, pantothenic acid, folic acid, niacin, choline, inositol, biotin.
Further, the diet essence includes cereal, beans, potato, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one of class, poultry meat, fruits;Wherein, the cereal include rice meal, millet powder, black rice flour, coixlacrymajobi powder,
At least one of corn flour, wheat germ powder, oatmeal, buckwheat, the beans include peameal, mung bean flour, black bean powder,
At least one of red bean powder, soy meal, the potato are mainly made of common yam rhizome powder, and the greengrocery includes carrot meal, white trailing plants
At least one of Bu Fen, pumpkin powder, spinach powder, tomato meal, broccoli powder, balsam pear powder, the Homonemeae include mushroom powder, sea
Band at least one of powder and white fungus powder, the nut-seed class includes at least one of pumpkin seed powder and lotus nut starch, described
Fish and shrimp include at least one of salmon powder and cod meal, and the poultry meat includes chicken meal, powdered beef and pig kidney powder
At least one of, the fruits include in red date powder, longan powder, apple powder, cherry powder, citrus powder, pyrus nivalis powder at least
It is a kind of.
Further, the integration of drinking and medicinal herbs ingredient include Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, campanulaceae, Gorgon fruit,
At least one of Chinese yam, hawthorn, Gallus domesticlus brisson, donkey-hide gelatin;Further, the integration of drinking and medicinal herbs ingredient is Fermented Soybean, Poria cocos, covers basin
Son, matrimony vine, sealwort, campanulaceae, Gorgon fruit, Chinese yam, parts by weight are respectively:0.01-0.1 parts of Fermented Soybean, 0.01-0.1 parts of Poria cocos,
0.01-0.1 parts of raspberry, 0.01-0.1 parts of matrimony vine, 0.01-0.1 parts of sealwort, 0.01-0.1 parts of campanulaceae, 0.01-0.1 parts of Gorgon fruit,
0.01-0.1 parts of Chinese yam;Or the integration of drinking and medicinal herbs ingredient be Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, campanulaceae, Gorgon fruit,
Chinese yam, Gallus domesticlus brisson, donkey-hide gelatin, parts by weight are respectively:0.01-0.1 parts of Fermented Soybean, 0.01-0.1 parts of Poria cocos, raspberry 0.01-
0.1 part, 0.01-0.1 parts of matrimony vine, 0.01-0.1 parts of sealwort, 0.01-0.1 parts of campanulaceae, 0.01-0.1 parts of Gorgon fruit, Chinese yam 0.01-
0.1 part, 0.01-0.1 parts of Gallus domesticlus brisson, 0.01-0.1 parts of donkey-hide gelatin.
Further, the natural plants compound includes l-cn, Glucosamine, oligofructose, lutein, plant
At least one of object sterol, lycopene, resveratrol, allicin;Further, the natural plants compound is a left side
Revolve carnitine.
Further, the new resource food includes milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo
In leaf flavones, casein phosphopeptide, avenabeta glucosan, yeast beta-dextran, newborn mineral salt, pueraria root powder, Rosa roxburghii Tratt, xylo-oligosaccharide
At least one;Further, the new resource food is avenabeta glucosan.
Further, the nephrosis dialysis tailored version clinical nutrition formula can also include nucleotide, and the nucleotide is
5'- monophosphate cytidines.
Second object of the present invention is to provide a kind of preparation method of above-mentioned nephrosis dialysis tailored version clinical nutrition formula,
Include the following steps:
Step 1, powder fat is prepared;
Step 2, integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, it will
The raw material of crushing is placed in container, and 3~8 times of the water that weight is raw material weight is added, carries out immersion 3~4 hours, then to leaching
Bubble liquid carries out 30~60min of decoction, and filtering removal raw material is left and taken decoction liquor, is spray-dried to decoction liquor, with 60~80 mesh
Screening prepares integration of drinking and medicinal herbs component powders;
Step 3, liposoluble vitamin powder and water soluble vitamin powder are prepared:By the fat-soluble dimension of predetermined weight number
Raw element is used as core material, selects carragheen, Arabic gum as wall material, carries out 2 emulsifying homogeneous processing, emulsifying homogeneous under high pressure
Time is 10~15min, then carries out instantaneous drying of spraying, liposoluble vitamin powder is prepared with 60~80 mesh screenings;It will be pre-
The water soluble vitamin of parts by weight is determined as core material, is selected maltodextrin, lipoprotein as wall material, is uniformly mixed, sprays wink
When dry, prepare water soluble vitamin powder with 60~80 mesh screenings;
Step 4, by the protein of predetermined weight and amino acid, nucleotide, carbohydrate, dietary fiber, macroelement,
Trace element, diet essence, natural plants compound and new resource food are prepared into the powder that grain size is 150~250 μm respectively
End;
Step 5, the mixing machine that the powder obtained by step 1~4 is sequentially added to cone-type mixer or other forms mixes
Uniformly obtained formula mixture, it is spare after sterilization processing;
Step 6, the formula mixture is prepared into nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution
At least one of;
Wherein, the sequence of step 1~4 can be replaced mutually.
Further, powder fat is prepared in the step 1 to specifically comprise the following steps:
1) wall material aqueous solution is prepared:Take maltodextrin 8g, soybean protein isolate 4g, whole-fat milk powder 11g, dietary fiber 2g,
Inulin 1.5g, PURE WHEY 5g, oligoisomaltose 0.5g, Arabic gum 0.2g, cornstarch 0.5g, tapioca 2g,
Water 50mL is stirred evenly, and can be heated while stirring when having ready conditions to 60 DEG C, keeps 30 minutes postcoolings to room temperature;The diet is fine
Dimension is preferably resistant dextrin;
2) monoglyceride is taken into 0.1g (a concentration of 0.2%) of total solid is uniformly dissolved in 10.8mL mixed plant greases;Institute
Mixed plant grease is stated by 2mL olive oil, 6.5mL soybean oils, 1.2mL coconut oil, 0.8mL perilla herb oils, 0.3mL medium chain triglycerides three
Ester forms;
3) Tween 80 is taken into 0.1g (a concentration of 0.2%) of total solid is uniformly dissolved in the wall material aqueous solution;
4) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed, obtains mixed solution;
5) (a concentration of 0.2%) of total solid is settled to after the mixed solution with water addition stabilizer agar 0.1g
(a concentration of 25%) of total solid, high speed dispersion 2 minutes, obtains emulsion to 200mL under 20000r/min;
6) by the emulsion at homogenization pressure 25MPa, homogeneous 3 times 5 minutes every time, obtains homogeneous emulsion;
7) the homogeneous emulsion is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C, is collected
To powder fat.
Further, optionally increase suitable food thickening agent and food additives in the step 6.Wherein,
The food thickening agent includes guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
At least one of, the food additives include at least one of Aspartame, food flavor fragrance, brown sugar.More preferably
For carragheen, Arabic gum, guar gum, Aspartame, food flavor fragrance.
Further, the operating procedure of the preparation method of above-mentioned nephrosis dialysis tailored version clinical nutrition formula is both needed in inertia
It is carried out under the protection of gas, used inert gas is nitrogen, argon gas, helium etc..On being carried out under the protection of inert gas
The danger of powder explosion can be prevented by stating operating procedure.
Using the integration of drinking and medicinal herbs for including raspberry, Poria cocos, campanulaceae, Fermented Soybean, matrimony vine, sealwort, Gorgon fruit, Chinese yam in the present invention
Ingredient has enhancing immunocompetence, improves oxygen radical removing ability, repairs renal function, suppression after mentioned component compatibility synergy
The benefits of kidney damage processed, contributes to nephrosis dialysis patient to absorb and supplement the nutrients, is conducive to the recovery of nephrosis dialysis patient.
Raspberry can be effectively improved glycometabolism, to inhibit and slow down diabetic nephropathy lesion;Improve renal blood flow, suppression
Kidney damage process processed;
It is rich in main active of the su-fuling as Poria cocos in Poria cocos, aldosterone receptor can be competed in vitro, reverses in vivo
Aldosterone effect does not influence aldosterone synthesis;To edematous patient, be conducive to the discharge of urine, restore renal function, eliminates albumen
Urine;
Platycodon root polysaccharide can effectively improve anti-fatigue ability, reduce blood urea nitrogen content, increase hepatic glycogen content;
Fermented Soybean mainly contains protein, fat, carbohydrate, vitamin etc., has antithrombase effect, can be used for delaying
Intravascular coagulation is solved, renal blood flow is improved, inhibits kidney damage process;
Matrimony vine has the benefits of qi-restoratives strengthening the essence, improve the immunity of the human body;
Siberian solomonseal rhizome polysaccharide has certain Renoprotective Effect, and having for kidney weight/weight value and nephridial tissue MDA levels improves
Effect, helps to improve oxygen radical removing ability;
Gorgon fruit also known as chicken head are real, sweet flat help, and puckery to restrain, property is gentle, the Gorgon fruit mixture formed using Gorgon fruit as main ingredient
With kidney tonifying, essence replenishing, strengthening the spleen and replenishing qi, respectful lung diuresis function has treatment chronic nephritis, all deficiency albuminuria of spleen kidney good
Effect;
Chinese yam has higher nutritional ingredient, has the benefits of strengthening spleen and nourishing stomach, easy to digest.
Meanwhile except above-mentioned integration of drinking and medicinal herbs ingredient, Gallus domesticlus brisson and donkey-hide gelatin both integration of drinking and medicinal herbs ingredients can also be added, with
It can be rapidly further that nephrosis dialysis patient supplements the nutrients comprehensively after mentioned component compatibility synergy, enhance immunocompetence, improve
Body quality.
Gallus domesticlus brisson has 10 kinds of amino acid, protein, vitamin B2, niacin, vitamin E, phosphorus, iron, potassium, sodium content more
Height, and cholesterol and fat content are then seldom, Chinese medicine think sweet Gallus domesticlus brisson smell, tepor, nontoxic, and edible Gallus domesticlus brisson is stopped with bowl spares
Bitterly, nourishing liver and kidney, blood-enrich, regulating menstruation and activating blood, only collapses and controls band and other effects at nourishing Yin and clearing heat, especially to the deficiency of vital energy of women, blood
Especially effective, the modern medicine study such as the diseases such as void, spleen deficiency, kidney deficiency and the slow, climacteric metancholia of women of children's upgrowth and development
Think that Gallus domesticlus brisson contains the indispensable lysine of human body, methionine and histidine, immune function of human body and anti-aging can be adjusted;Its
Be conducive to nephrosis dialysis patient rapidly to supplement the nutrients comprehensively, and can have with inflammation to alleviate by enhancing immune function of human body
The malnutrition of pass promotes nephrosis to restore;
It is the severe complication of chronic kidney hypofunction that donkey-hide gelatin, which has powerful blood tonification effect, anaemia, and haemodialysis can improve
The Water-Electrolyte of Chronic Renal Failure Patients, acid-base imbalance state remove uremic toxins, but cannot improve anaemia, and donkey-hide gelatin has aobvious
Work improves red blood cell and hemoglobin, the effect for promoting hematopoiesis function, contributes to the generation for inhibiting anaemia, keeps nephrosis dialysis
The stabilization of patient body quality.
The present invention is had the following technical effect that compared with prior art using above-mentioned technical proposal:
1) nephrosis of the invention dialysis tailored version clinical nutrition formula uses 18.6:24.1:57.3 protein:Fat:
The energy supply ratio of carbohydrate provides balanced nutritional supplementation for patient.
2) protein source of the present invention is in lactalbumin, soybean protein isolate, whole milk powder, dried whole-egg, sea
Foreign fish oligopeptide, oligopeptide refer to average molecular weight be 1000D or less, by bio-enzyme engineering technology from animal or vegetable protein
The small molecule protein of middle separation and Extraction, have the characteristics that it is soluble easily in water, to acid, it is heat-staple, be not required to digest in human body
It can directly absorb, bioavailability is high, and oligopeptide also has a series of physiology other than having corresponding trophic function
Absorption and supplement, anti-sports fatigue, raising immunity, auxiliary adjustment blood pressure blood fat, antioxygen of the active function as promoted electrolyte
Change, is antitumor, promoting the effects that bone growth.
3) 8-12 parts of fat of present invention addition, addition 4:1 ω -6 unsaturated fatty acids and omega-3 unsaturated fatty acid, energy
Anti-inflammatory and vasoactive factors are enough generated, injury of kidney process is changed, reduce blood lipid level;Also add medium chain triglyceride, middle chain
Triglycerides has the characteristics that energy supply is rapid, improves fat metabolism speed, will not inhibit immune system, nor affect on cholesterol generation
It thanks, additionally it is possible to enhance absorption of the human body to calcium, magnesium and amino acid.
4) present invention addition prebiotics galactooligosaccharide, oligoisomaltose;Prebiotics can promote probiotics enteron aisle fixed
It plants, enteron aisle convergence, reduce enteron aisle PH environment, the growth and breeding of human body beneficial bacteria is promoted to be helped to inhibit spoilage organisms to grow
In improvement and maintain enteron aisle normal function;Long-term consumption can improve immunity, mitigate burden of liver, anti-aging, promote row
Just.Oligoisomaltose is most excellent strain in prebiotics.
5) it is saturating can to prevent nephrosis using low-phosphorous, low potassium, the nephrosis dialysis tailored version clinical nutrition formula of low sodium by the present invention
There are the clinical symptoms such as hyperphosphatemia and renal osteodystrophy in analysis patient.
6) present invention addition trace selenium, selenium can improve patient's glomerular filtration rate, mitigate the hair of nephrosis dialysis patient inflammation
It is raw, there is protective effect, selenium can also improve the immunity of patient, the Hb values of patient be improved, to renal anemia the kidney of patient
It makes moderate progress, preferably protects the renal function of patient, delay the progress of kidney trouble.
7) present invention addition Semen phaseoli radiati extract, Semen phaseoli radiati extract have extensive bacteriostatic activity, wherein n-butyl alcohol extract
For the effective extract of bacteriostatic activity, there is different inhibition to make bacillus subtilis, staphylococcus albus, Escherichia coli, mould
With the relevant malnutrition of inflammation can be effectively relieved, improve the body quality of patient.
8) tremella polysaccharides that the present invention adds can adjust the activity of glycometabolism enzyme, and islet secretion insulin is promoted to inhibit sugar
Heteroplasia promotes utilization of the peripheral tissues to glucose, to have the function that hypoglycemic, raising immunity.
The present invention by select rational proportion basal nutrient element, while add with immunocompetence, improve renal anemia,
Alleviate inflammation, the dietary fiber for enhancing human nutrition absorbability, diet essence, integration of drinking and medicinal herbs ingredient, natural plants compound
And the special dietaries substance such as new resource food, and adjust its proportioning and carry out compatibility synergy, the present invention made with basal nutrient element
Nephrosis dialysis tailored version clinical nutrition formula be easier to be absorbed by nephrosis dialysis patient, to give full play to the work(of each component
It is underfed to solve nephrotic's simple malnutritive or Nosocomial of generally existing during haemodialysis for effect
Situation improves body quality, accelerates the state of an illness and restores.
Specific implementation mode
The present invention provides a kind of nephrosis dialysis tailored version clinical nutrition formulas comprising following component and its parts by weight
Number:15-25 parts of protein, 8-12 parts of fat, 50-54 parts of carbohydrate, 3-5 parts of dietary fibers, 0.3-0.6 parts of constant members
Element, 0.01-0.05 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.01-0.2 parts of water soluble vitamins, 0.05-1
Part diet essence, 0.05-2 parts of integration of drinking and medicinal herbs ingredients, 0.1-3 parts of natural plants compounds and 0.005-2 parts of new resource foods;
Wherein, the fat includes medium chain triglyceride;Wherein, the dietary fiber selects water-soluble dietary fiber.
The present invention is described in more detail below by specific embodiment, for a better understanding of the present invention,
But following embodiments are not intended to limit the scope of the invention.
Embodiment 1
Nephrosis dialysis tailored version clinical nutrition formula of the present invention includes PURE WHEY 12.8g, soybean separation protein
White 6.8g, whole milk powder 4g, dried whole-egg 0.18g, colostrum 0.1g, taurine 0.12g, ocean fish oligopeptide 0.1g;Olive oil
1.82g, soybean oil 5.82g, coconut oil 1.1g, perilla herb oil 0.73g, medium chain triglyceride 0.24g;Maltodextrin 37.53g, wood
Sweet potato starch 9.45g, cornstarch 5.46g;Water-soluble dietary fiber 4.55g in dietary fiber;Calcium 0.29g, phosphorus in macroelement
0.12g, potassium 0.02g, sodium 0.05g, magnesium 0.1g;Iron 0.011g, iodine 0.00014g, zinc 0.016g, selenium in trace element
0.00006g, copper 0.0004g, manganese 0.0001g;Vitamin A 0.0005g, beta carotene in liposoluble vitamin
0.000057g, vitamin D30.000001g, vitamin E 0.008g;Vitamin B in water soluble vitamin10.001g, dimension life
Plain B20.001g, vitamin B60.0002g, vitamin B120.000001g, vitamin C 0.102g, pantothenic acid 0.003g, leaf
Sour 0.000023g, niacin 0.0133g;Mung bean flour 0.1g, white fungus powder 0.1g, broccoli powder 0.1g, salmon powder 0.1g, chicken
0.1g;Fermented Soybean 0.1g, Poria cocos 0.1g, raspberry 0.1g, matrimony vine 0.1g, sealwort 0.1g, campanulaceae 0.1g, Gorgon fruit 0.1g, Chinese yam
0.1g, l-cn 0.64g, avenabeta glucosan 0.02g.
Embodiment 2
Nephrosis dialysis tailored version clinical nutrition formula of the present invention includes PURE WHEY 12.8g, soybean separation protein
White 6.8g, whole milk powder 4g, dried whole-egg 0.18g, colostrum 0.1g, taurine 0.12g, ocean fish oligopeptide 0.1g;Olive oil
1.82g, soybean oil 5.82g, coconut oil 1.1g, perilla herb oil 0.73g, medium chain triglyceride 0.24g;Maltodextrin 37.53g, wood
Sweet potato starch 9.45g, cornstarch 5.46g;Water-soluble dietary fiber 4.55g in dietary fiber;Calcium 0.29g, phosphorus in macroelement
0.12g, potassium 0.02g, sodium 0.05g, magnesium 0.1g;Iron 0.011g, iodine 0.00014g, zinc 0.016g, selenium in trace element
0.00006g, copper 0.0004g, manganese 0.0001g;Vitamin A 0.0005g, beta carotene in liposoluble vitamin
0.000057g, vitamin D30.000001g, vitamin E 0.008g;Vitamin B in water soluble vitamin10.001g, dimension life
Plain B20.001g, vitamin B60.0002g, vitamin B120.000001g, vitamin C 0.102g, pantothenic acid 0.003g, leaf
Sour 0.000023g, niacin 0.0133g;Mung bean flour 0.1g, white fungus powder 0.1g, broccoli powder 0.1g, salmon powder 0.1g, chicken
0.1g;Fermented Soybean 0.1g, Poria cocos 0.1g, raspberry 0.1g, matrimony vine 0.1g, sealwort 0.1g, campanulaceae 0.1g, Gorgon fruit 0.1g, Chinese yam
0.1g, Gallus domesticlus brisson 0.1g, donkey-hide gelatin 0.1g;L-cn 0.64g, avenabeta glucosan 0.02g.
Embodiment 3
Nephrosis dialysis tailored version clinical nutrition formula of the present invention includes PURE WHEY 5.8g, soybean protein isolate
13.8g, whole milk powder 4g, dried whole-egg 0.18g, colostrum 0.1g, taurine 0.12g, ocean fish oligopeptide 0.1g;Olive oil
1.82g, soybean oil 5.82g, coconut oil 1.1g, perilla herb oil 0.73g, medium chain triglyceride 0.24g;Maltodextrin 37.53g, wood
Sweet potato starch 9.45g, cornstarch 5.46g;Water-soluble dietary fiber 4.55g in dietary fiber;Calcium 0.29g, phosphorus in macroelement
0.12g, potassium 0.02g, sodium 0.05g, magnesium 0.1g;Iron 0.011g, iodine 0.00014g, zinc 0.016g, selenium in trace element
0.00006g, copper 0.0004g, manganese 0.0001g;Vitamin A 0.0005g, beta carotene in liposoluble vitamin
0.000057g, vitamin D30.000001g, vitamin E 0.008g;Vitamin B in water soluble vitamin10.001g, dimension life
Plain B20.001g, vitamin B60.0002g, vitamin B120.000001g, vitamin C 0.102g, pantothenic acid 0.003g, leaf
Sour 0.000023g, niacin 0.0133g;Mung bean flour 0.1g, white fungus powder 0.1g, broccoli powder 0.1g, salmon powder 0.1g, chicken
0.1g;Fermented Soybean 0.1g, Poria cocos 0.1g, raspberry 0.1g, matrimony vine 0.1g, sealwort 0.1g, campanulaceae 0.1g, Gorgon fruit 0.1g, Chinese yam
0.1g, l-cn 0.64g, avenabeta glucosan 0.02g.
Embodiment 4
Nephrosis dialysis tailored version clinical nutrition formula of the present invention includes PURE WHEY 12.8g, soybean separation protein
White 6.8g, whole milk powder 4g, dried whole-egg 0.18g, colostrum 0.1g, taurine 0.12g, ocean fish oligopeptide 0.1g;Olive oil
1.82g, soybean oil 5.82g, coconut oil 1.1g, perilla herb oil 0.73g, medium chain triglyceride 0.24g;Maltodextrin 37.53g, wood
Sweet potato starch 9.45g, cornstarch 5.46g;Water-soluble dietary fiber 4.55g in dietary fiber;Calcium 0.29g, phosphorus in macroelement
0.12g, potassium 0.02g, sodium 0.05g, magnesium 0.1g;Iron 0.011g, iodine 0.00014g, zinc 0.016g, selenium in trace element
0.00006g, copper 0.0004g, manganese 0.0001g;Vitamin A 0.0005g, beta carotene in liposoluble vitamin
0.000057g, vitamin D30.000001g, vitamin E 0.008g;Vitamin B in water soluble vitamin10.001g, dimension life
Plain B20.001g, vitamin B60.0002g, vitamin B120.000001g, vitamin C 0.102g, pantothenic acid 0.003g, leaf
Sour 0.000023g, niacin 0.0133g;Mung bean flour 0.01g, white fungus powder 0.01g, broccoli powder 0.01g, salmon powder 0.01g,
Chicken 0.01g;Fermented Soybean 0.01g, Poria cocos 0.01g, raspberry 0.01g, matrimony vine 0.01g, sealwort 0.01g, campanulaceae 0.01g, Gorgon euryale
Real 0.01g, Chinese yam 0.01g, l-cn 0.64g, avenabeta glucosan 0.02g.
Embodiment 5
A kind of preparation method of nephrosis dialysis tailored version clinical nutrition formula as described in 1~embodiment of embodiment 4 is as follows:
1) powdered oil (powder fat) is prepared:
A) wall material aqueous solution is prepared:Take maltodextrin 8g, soybean protein isolate 4g, whole-fat milk powder 11g, dietary fiber 2g
(resistant dextrin), inulin 1.5g, PURE WHEY 5g, oligoisomaltose 0.5g, Arabic gum 0.2g, cornstarch 0.5g,
Tapioca powder 2g, water 50mL are stirred evenly and (are had ready conditions and heat while stirring to 60 DEG C, keep 30 minutes postcoolings to room temperature).
B) by monoglyceride take 0.1g (a concentration of 0.2%) of total solid be uniformly dissolved in 10.8mL greases (olive oil 2mL,
Soybean oil 6.5mL, coconut oil 1.2mL, perilla herb oil 0.8mL, medium chain triglyceride 0.3mL).
C) Tween 80 is taken into 0.1g (a concentration of 0.2%) of total solid is uniformly dissolved in wall material aqueous solution.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar takes 0.1g (a concentration of 0.2%) of total solid is settled into after mixed solution with water
200mL (a concentration of 25%) of total solid, high speed dispersion 2 minutes under 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous emulsion is made in homogeneous 3 times (every time 5 minutes).
G) emulsion obtained is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C.Collect powder
Grease (powder fat).
2) integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, be added weight be raw material weight 3~8 times of water, immersion is carried out 3~4 hours, then to soak
30~60min of decoction is carried out, filtering removal raw material is left and taken decoction liquor, is spray-dried to decoction liquor, sieved with 60~80 mesh
Prepare integration of drinking and medicinal herbs component powders;
3) vitamin powder is prepared:Using the liposoluble vitamin of predetermined weight number as core material, select carragheen, I
Primary glue carries out 2 emulsifying homogeneous processing, the emulsifying homogeneous time is 10~15min, is then sprayed under high pressure as wall material
It is instantaneous dry, prepare liposoluble vitamin powder with 60~80 mesh screenings;Using the water soluble vitamin of predetermined weight number as
Core material is selected maltodextrin, lipoprotein as wall material, is uniformly mixed, and sprays instantaneous dry, is prepared with the screening of 60~80 mesh water-soluble
Property vitamin powder;
4) by the protein of predetermined weight and amino acid, nucleotide, carbohydrate, dietary fiber, macroelement, micro
Element, diet essence, natural plants compound and new resource food prepare the powder that granulating grain size is 150~250 μm respectively;
5) mixing machine that the powder obtained by step 1)~step 4) is sequentially added to cone-type mixer or other forms is mixed
Uniformly obtained formula mixture is closed, it is spare after sterilization processing;
6) according to conventional technical means by the formula mixture in step 5) be prepared into nutrient powder, nutrition emulsion, capsule,
At least one of tablet, pill or oral solution.
In step 6), optionally increase suitable food thickening agent and food additives.The food thickening agent
It is described at least one of guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
Food additives are at least one of Aspartame, food flavor fragrance, brown sugar;More preferable carragheen, Arabic gum, Guar
Glue, Aspartame, food flavor fragrance.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent from producing
The danger of green powder explosion.
According to described with the classifications such as powdery, graininess, capsule shape, tablet shape, beverage can be prepared into.
Embodiment 6
The present embodiment is verification embodiment.
This verification embodiment verifies nephrosis of the present invention and dialyses tailored version clinical nutrition formula to nephrosis dialysis patient
Influence.Electuary and following comparative example of the present embodiment using the formula preparation of Examples 1 and 2:
Control group:Person in middle and old age's Nutrious milk powder (Erie);
Experimental group 1:The electuary prepared using the nutrient formulation of embodiment 1;
Experimental group 2:The electuary prepared using the nutrient formulation of embodiment 2;
Experimental group 3:The electuary prepared using dietary fiber is deleted in the nutrient formulation of embodiment 1;
Experimental group 4:The electuary prepared using integration of drinking and medicinal herbs ingredient is deleted in the nutrient formulation of embodiment 1;
The gerontal patient 30 of the nephrosis dialysis of corresponding electuary is voluntarily taken in every group of selection above, and each group patient carries out often
Rule nursing.According to the normal nutrition intake of patient, the electuary of the present invention is given in the time of normally ingesting, 4 times a day, original dialysis
Number and medicine type and quantity are constant.Experimental result statistics is carried out after 2 months, experimental result is average value, experiment
The results are shown in table below:
The variation of the edible front and back nephrosis dialysis patient clinical indices of table one
As seen from the above table, nephrosis of the invention dialysis tailored version clinical nutrition formula can be effectively improved the battalion of nephrosis dialysis
The state of supporting, contributes to patient to restore.The effect of embodiment 2 is better than other experimental groups.
By above-described embodiment it is found that each component cooperates in the nephrosis dialysis tailored version clinical nutrition formula of the present invention,
Reasonable, comprehensive, balanced nutritional support is provided for nephrosis dialysis patient, to improve the physical condition of nephrosis dialysis patient, keep
The stabilization of patient body quality, booster immunization responsibility, at the same add dietary fiber, diet essence, integration of drinking and medicinal herbs ingredient,
Natural plants compound and new resource food etc., which have, to be improved immunocompetence, repairs renal function, the state that reduces inflammation, inhibits
Kidney damage improves oxygen radical removing ability and inner skin cell function, contributes to the absorption of nephrosis dialysis patient and Replacement Battalion
It supports, reduces nephrosis dialysis patient case fatality rate and complication rate, advantageously reduce the underfed occurrence risk of patient, promoted
The prognostic level of patient is conducive to the recovery of nephrosis dialysis patient.
Specific embodiments of the present invention are described in detail above, but it is intended only as example, the present invention is simultaneously unlimited
It is formed on particular embodiments described above.To those skilled in the art, it is any to the equivalent modifications that carry out of the present invention and
It substitutes also all among scope of the invention.Therefore, without departing from the spirit and scope of the invention made by impartial conversion and
Modification, all should be contained within the scope of the invention.
Claims (10)
- The tailored version clinical nutrition formula 1. a kind of nephrosis is dialysed, which is characterized in that including following component and its parts by weight:15- 25 parts of protein, 8-12 parts of fat, 50-54 parts of carbohydrate, 3-5 parts of dietary fibers, 0.3-0.6 parts of macroelements, 0.01- 0.05 part of trace element, 0.005-0.02 parts of liposoluble vitamins, 0.01-0.2 parts of water soluble vitamins, 0.05-1 parts of diet essences China, 0.05-2 parts of integration of drinking and medicinal herbs ingredients, 0.1-3 parts of natural plants compounds and 0.005-2 parts of new resource foods;Wherein, in the nutrient formulation, protein:Fat:The productivity ratio of carbohydrate is 15~20:20~25:50~60.Wherein, the integration of drinking and medicinal herbs ingredient includes Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, campanulaceae, Gorgon fruit, Chinese yam, mountain At least one of short, bristly hair or beard, Gallus domesticlus brisson, donkey-hide gelatin.
- The tailored version clinical nutrition formula 2. a kind of nephrosis according to claim 1 is dialysed, which is characterized in that the protein Including in lactalbumin, soybean protein isolate, whole milk powder, dried whole-egg, ocean fish oligopeptide, colostrum, taurine at least It is a kind of.
- The tailored version clinical nutrition formula 3. a kind of nephrosis according to claim 1 is dialysed, which is characterized in that the fat packet Include medium chain triglyceride, olive oil, soybean oil, coconut oil, perilla herb oil.
- The tailored version clinical nutrition formula 4. a kind of nephrosis according to claim 1 is dialysed, which is characterized in that the diet is fine Dimension include inulin, konjaku flour, galactooligosaccharide, oligofructose, oligoisomaltose, soybean polyoses, cyclodextrin, resistant dextrin, At least one of soybean fiber.
- The tailored version clinical nutrition formula 5. a kind of nephrosis according to claim 1 is dialysed, which is characterized in that the diet is fine Dimension selects water-soluble dietary fiber.
- The tailored version clinical nutrition formula 6. a kind of nephrosis according to claim 1 is dialysed, which is characterized in that the micro member The parts by weight of selenium are 0.00001~0.0001 part in element.
- The tailored version clinical nutrition formula 7. a kind of nephrosis according to claim 1 is dialysed, which is characterized in that the diet essence China include cereal, beans, potato, greengrocery, Homonemeae, nut-seed class, fish and shrimp, poultry meat, in fruits at least It is a kind of;Wherein, the cereal includes rice meal, millet powder, black rice flour, coixlacrymajobi powder, corn flour, wheat germ powder, oatmeal, buckwheat At least one of flour, the beans include at least one of peameal, mung bean flour, black bean powder, red bean powder, soy meal, The potato is mainly made of common yam rhizome powder, the greengrocery include carrot meal, white radish powder, pumpkin powder, spinach powder, tomato meal, At least one of broccoli powder, balsam pear powder, the Homonemeae include at least one of mushroom powder, Kelp Powder and white fungus powder, The nut-seed class includes at least one of pumpkin seed powder and lotus nut starch, and the fish and shrimp include salmon powder and cod meal At least one of, the poultry meat includes at least one of chicken meal, powdered beef and pig kidney powder, and the fruits include At least one of red date powder, longan powder, apple powder, cherry powder, citrus powder, pyrus nivalis powder.
- 8. the preparation method of the nephrosis dialysis tailored version clinical nutrition formula according to any one of claim 1-7, special Sign is, includes the following steps:Step 1, powder fat is prepared;Step 2, integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed Raw material be placed in container, be added weight be raw material weight 3~8 times of water, immersion is carried out 3~4 hours, then to soak 30~60min of decoction is carried out, filtering removal raw material is left and taken decoction liquor, is spray-dried to decoction liquor, sieved with 60~80 mesh Prepare integration of drinking and medicinal herbs component powders;Step 3, liposoluble vitamin powder and water soluble vitamin powder are prepared:By the liposoluble vitamin of predetermined weight number It as core material, selects carragheen, Arabic gum as wall material, carries out 2 emulsifying homogeneous processing, emulsifying homogeneous time under high pressure For 10~15min, instantaneous drying of spraying then is carried out, liposoluble vitamin powder is prepared with 60~80 mesh screenings;By predetermined weight The water soluble vitamin of number is measured as core material, selects maltodextrin, lipoprotein as wall material, is uniformly mixed, spray instantaneous dry It is dry, prepare water soluble vitamin powder with 60~80 mesh screenings;Step 4, by the protein of predetermined weight and amino acid, nucleotide, carbohydrate, dietary fiber, macroelement, micro Element, diet essence, natural plants compound and new resource food are prepared into the powder that grain size is 150~250 μm respectively;Step 5, the powder obtained by step 1~4 is sequentially added into mixing machine and is uniformly mixed obtained formula mixture, by sterilization It is spare after processing;Step 6, the formula mixture is prepared into nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution It is at least one;Wherein, the sequence of step 1~4 can be replaced mutually.
- 9. preparation method according to claim 8, which is characterized in that prepare powder fat in the step 1 and specifically include Following steps:1) wall material aqueous solution is prepared:Take maltodextrin 8g, soybean protein isolate 4g, whole-fat milk powder 11g, dietary fiber 2g, inulin 1.5g, PURE WHEY 5g, oligoisomaltose 0.5g, Arabic gum 0.2g, cornstarch 0.5g, tapioca 2g, water 50mL is stirred evenly;2) monoglyceride is taken into 0.1g (a concentration of 0.2%) of total solid is uniformly dissolved in 10.8mL mixed plant greases;It is described mixed Vegetable fat is closed by 2mL olive oil, 6.5mL soybean oils, 1.2mL coconut oil, 0.8mL perilla herb oils, 0.3mL medium chain triglyceride groups At;3) Tween 80 is taken into 0.1g (a concentration of 0.2%) of total solid is uniformly dissolved in the wall material aqueous solution;4) the mixed plant grease and the wall material aqueous solution of addition Over emulsfication agent Tween 80 that add Over emulsfication agent monoglyceride is abundant Mixing, obtains mixed solution;5) (a concentration of 0.2%) of total solid is settled to 200mL to addition stabilizer agar 0.1g after the mixed solution with water (a concentration of 25%) of total solid, high speed dispersion 2 minutes, obtains emulsion under 20000r/min;6) by the emulsion at homogenization pressure 25MPa, homogeneous 3 times 5 minutes every time, obtains homogeneous emulsion;7) the homogeneous emulsion is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C, and collection obtains powder Last fat.
- 10. preparation method according to claim 8, which is characterized in that the step 6 is added with food and thickens in the preparation Agent and food additives;Wherein, the food thickening agent include guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, At least one of Arabic gum, the food additives include at least one in Aspartame, food flavor fragrance, brown sugar Kind.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810444527.1A CN108651988A (en) | 2018-05-10 | 2018-05-10 | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810444527.1A CN108651988A (en) | 2018-05-10 | 2018-05-10 | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108651988A true CN108651988A (en) | 2018-10-16 |
Family
ID=63778275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810444527.1A Pending CN108651988A (en) | 2018-05-10 | 2018-05-10 | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108651988A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109497514A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | AIDS tailored version clinical nutrition formula and preparation method thereof |
CN109497520A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of self-closing disease tailored version clinical nutrition composition and preparation method thereof |
CN109497563A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | Leucoderma tailored version clinical nutrition formula and preparation method thereof |
CN110200273A (en) * | 2019-06-06 | 2019-09-06 | 王仲 | A kind of clinical liver disease nutritious food and preparation method thereof |
CN110226743A (en) * | 2019-07-05 | 2019-09-13 | 济南大学 | A kind of Adult chronic's kidney trouble nontransparent PCI-PCI bridge wholefood formula and preparation method thereof |
CN110463989A (en) * | 2019-07-24 | 2019-11-19 | 浙江禾健生营养科技有限公司 | A kind of full nutrient formulation powder of nephrosis tailored version and preparation method thereof |
CN112120222A (en) * | 2020-10-08 | 2020-12-25 | 菏泽嘉麟生物科技有限公司 | Method for preparing bioengineering fermented selenium product |
CN114868911A (en) * | 2022-05-19 | 2022-08-09 | 陕西巨子生物技术有限公司 | Medical nutrition powder for kidney disease non-dialysis patients and preparation method thereof |
CN115054677A (en) * | 2022-03-24 | 2022-09-16 | 大医声科技(北京)有限公司 | Multi-vitamin nutrient formula suitable for patients with nephropathy |
CN115137059A (en) * | 2022-05-23 | 2022-10-04 | 青岛普瑞森医药科技有限公司 | Non-full-nutrition food for improving nephropathy and preparation process thereof |
CN115226825A (en) * | 2022-06-21 | 2022-10-25 | 肖玉顺 | Functional solid beverage |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
CN107319524A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
CN107440103A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of respiratory disease tailored version clinical nutrition formula and preparation method thereof |
-
2018
- 2018-05-10 CN CN201810444527.1A patent/CN108651988A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106942748A (en) * | 2017-03-29 | 2017-07-14 | 上海奥医生物医药科技有限公司 | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983151A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
CN107319524A (en) * | 2017-06-29 | 2017-11-07 | 上海复旦奥医医学科技有限公司 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
CN107440103A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of respiratory disease tailored version clinical nutrition formula and preparation method thereof |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109497514A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | AIDS tailored version clinical nutrition formula and preparation method thereof |
CN109497563A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | Leucoderma tailored version clinical nutrition formula and preparation method thereof |
CN109497520A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of self-closing disease tailored version clinical nutrition composition and preparation method thereof |
CN110200273A (en) * | 2019-06-06 | 2019-09-06 | 王仲 | A kind of clinical liver disease nutritious food and preparation method thereof |
CN110226743A (en) * | 2019-07-05 | 2019-09-13 | 济南大学 | A kind of Adult chronic's kidney trouble nontransparent PCI-PCI bridge wholefood formula and preparation method thereof |
CN110463989A (en) * | 2019-07-24 | 2019-11-19 | 浙江禾健生营养科技有限公司 | A kind of full nutrient formulation powder of nephrosis tailored version and preparation method thereof |
CN112120222A (en) * | 2020-10-08 | 2020-12-25 | 菏泽嘉麟生物科技有限公司 | Method for preparing bioengineering fermented selenium product |
CN115054677A (en) * | 2022-03-24 | 2022-09-16 | 大医声科技(北京)有限公司 | Multi-vitamin nutrient formula suitable for patients with nephropathy |
CN114868911A (en) * | 2022-05-19 | 2022-08-09 | 陕西巨子生物技术有限公司 | Medical nutrition powder for kidney disease non-dialysis patients and preparation method thereof |
CN115137059A (en) * | 2022-05-23 | 2022-10-04 | 青岛普瑞森医药科技有限公司 | Non-full-nutrition food for improving nephropathy and preparation process thereof |
CN115226825A (en) * | 2022-06-21 | 2022-10-25 | 肖玉顺 | Functional solid beverage |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108651988A (en) | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof | |
CN101278736B (en) | Balanced enteral total nutrient preparation suitable for nutrition support of Asian population | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN106616615A (en) | Clinical nutrient formula special for tumor and preparation method of clinical nutrient formula | |
CN106490605A (en) | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof | |
CN106666728A (en) | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition | |
CN110326782A (en) | A kind of nutritional meal replacement and preparation method thereof with effect of weight reducing | |
CN108618129A (en) | Sarcopenia tailored version clinical nutrition formula and preparation method thereof | |
CN106983151A (en) | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof | |
CN106072573A (en) | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible | |
CN108013454A (en) | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof | |
CN108013453A (en) | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof | |
CN105211884A (en) | For alimentation composition edible after Diabetic Nephropathy patients dialysis and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
CN101473953A (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN1843130A (en) | Brain tonic flour and food production method | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
CN103431392B (en) | Composite marine food for special dietary uses for diabetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181016 |
|
RJ01 | Rejection of invention patent application after publication |